BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Topadur Pharma Appoints New CEO to Drive Growth CEO Appointment Clinical Development Topadur Pharma Dr. Matthias Schäfer Vascular Regeneration
BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Designated Person Notification by Aperam Share Transactions Aperam Market Abuse Luxembourg Stock Exchange Designated Person
BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Topadur Pharma nomme un nouveau PDG pour stimuler sa croissance Développement Clinique Nomination Du PDG Topadur Pharma Dr Matthias Schäfer Régénération Vasculaire
BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Notification de transaction d'une personne désignée chez Aperam Transparence Aperam Marché Boursier Règlement UE Personne Désignée
BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Notification de la personne désignée par Aperam Aperam Abus De Marché Bourse De Luxembourg Transactions Sur Actions Personne Désignée
BRIEF published on 12/17/2025 at 09:35, 5 days 2 hours ago Transaction notification from a designated person at Aperam Transparency Stock Market Aperam EU Regulation Designated Person
BRIEF published on 12/17/2025 at 09:26, 5 days 2 hours ago Heidelberg Pharma Faces Financial Hurdles Amid Strategic Adjustments Clinical Trials Cancer Research Cost-cutting Heidelberg Pharma Financial Challenges
BRIEF published on 12/17/2025 at 09:26, 5 days 2 hours ago Heidelberg Pharma confrontée à des difficultés financières dans un contexte d'ajustements stratégiques Essais Cliniques Réduction Des Coûts Heidelberg Pharma Défis Financiers Recherche Sur Le Cancer
BRIEF published on 12/17/2025 at 09:10, 5 days 2 hours ago Norgine Secures Licensing Deal with Vir Biotechnology for Hepatitis Delta Treatment Pharmaceuticals Licensing Agreement Norgine Vir Biotechnology Hepatitis Delta
BRIEF published on 12/17/2025 at 09:10, 5 days 2 hours ago Norgine conclut un accord de licence avec Vir Biotechnology pour le traitement de l'hépatite delta. Médicaments Contrat De Licence Norgine Vir Biotechnology Hépatite Delta
Published on 12/22/2025 at 08:05, 4 hours 1 minute ago Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
Published on 12/20/2025 at 00:30, 2 days 11 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 14 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 17 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 21 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/22/2025 at 11:55, 10 minutes ago Monport Germany Prepares for Holiday with Seasonal Opportunities for Fiber Laser and CO2 Lasers
Published on 12/22/2025 at 11:25, 40 minutes ago DNB chooses Stacc to revolutionise mortgages in Norway
Published on 12/22/2025 at 11:15, 50 minutes ago 'Healing Journey Thailand' – TAT Prepares Global Campaign to Position Thailand as a World-Class Healing Destination
Published on 12/22/2025 at 09:18, 2 hours 47 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 2 hours 47 minutes ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 14 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 3 days 3 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 3 days 3 hours ago Réduction du capital par voie d’annulation d’actions propres
